Stockscreener 앱 받기
1.02
3.03%
0.03
시간 외 거래:
.97
-0.05
-4.90%
전일 마감가:
$0.99
열려 있는:
$1.01
하루 거래량:
243.76K
Relative Volume:
0.31
시가총액:
$99.11M
수익:
$11.03M
순이익/손실:
$-44.24M
주가수익비율:
-1.6452
EPS:
-0.62
순현금흐름:
$-42.61M
1주 성능:
+12.62%
1개월 성능:
-5.56%
6개월 성능:
+27.50%
1년 성능:
-0.97%
1일 변동 폭
$0.9713
$1.05
1주일 범위
$0.8694
$1.05
52주 변동 폭
$0.5327
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
명칭
Hyperfine Inc
전화
866-796-6767
주소
351 NEW WHITFIELD STREET, GUILFORD
HYPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
1.02 | 96.20M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
127.78 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.79 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.39 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.31 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.85 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | 개시 | Evercore ISI | Outperform |
| 2022-04-14 | 개시 | Wells Fargo | Overweight |
Hyperfine Inc 주식(HYPR)의 최신 뉴스
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care - Business Wire
How Hyperfine Inc. stock valuations compare to rivals2026 world cup usa national team quarterfinals goalkeepers transition play knockout prediction insights - Улправда
The Truth About Hyperfine Inc: Tiny Stock, Huge Hype – Is HYPR the Next Sleeper Moonshot? - AD HOC NEWS
Hyperfine gets FDA clearance for diffusion-weighted imaging software sequence - MSN
Hyperfine, Inc. (NASDAQ:HYPR) Short Interest Down 15.6% in December - MarketBeat
Hyperfine Inc. Reports Promising Growth in Latest Earnings Call - MSN
Hyperfine amends at-the-market sales agreement to add BTIG as sales agent - Investing.com Australia
Hyperfine amends at-the-market sales agreement to add BTIG as sales agent By Investing.com - Investing.com South Africa
Hyperfine Expands ATM Equity Offering With New Sales Agent - TipRanks
Hyperfine Signs Amended ATM Sales Agreement With B. Riley Securities and BTIG - TradingView — Track All Markets
12 Health Care Stocks Moving In Monday's Pre-Market Session - Sahm
Hyperfine stock tumbles after direct offering announcement - MSN
Hyperfine announces regulatory approval of Swoop system in India - MSN
Can Hyperfine Inc. stock hit analyst price targetsVolume Spike & Weekly Momentum Picks - Улправда
Aug Patterns: Can Hyperfine Inc. stock hit analyst price targetsWeekly Stock Report & Growth Focused Entry Reports - Улправда
Why Hyperfine Inc. stock is favored by top institutionsMarket Activity Report & Weekly Stock Breakout Alerts - Улправда
Transcript : Hyperfine, Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-04-2025 08 - marketscreener.com
Can Hyperfine Inc. stock rebound after recent weakness2025 Sector Review & Safe Capital Growth Trade Ideas - DonanımHaber
Can Hyperfine Inc. stock maintain growth trajectoryTrade Analysis Report & Free Safe Entry Trade Signal Reports - DonanımHaber
US-based Hyperfine receives regulatory approval of Swoop® System in India for brain imaging - BioSpectrum Asia
Hyperfine (HYPR) Receives a Buy from Lake Street - The Globe and Mail
Hyperfine’s portable MRI system receives regulatory approval in India By Investing.com - Investing.com Nigeria
Hyperfine Announces Regulatory Approval of the Swoop® System in India - 01net
Hyperfine’s portable MRI system receives regulatory approval in India - Investing.com
Hyperfine announces regulatory approval of the Swoop® system in India - marketscreener.com
Hyperfine, Inc. Announces Regulatory Approval of the Swoop®? System in India - marketscreener.com
Hyperfine (NASDAQ:HYPR) Shares Down 6.8%Should You Sell? - MarketBeat
Hyperfine Gets FDA OK for Optive AI Update with Advanced Diffusion Imaging - Medical Product Outsourcing
Hyperfine receives FDA clearance for multi-direction DWI sequence By Investing.com - Investing.com Nigeria
Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System - 01net
Hyperfine Receives FDA Clearance for Software Update for Portable MRI System for the Brain - Imaging Technology News
Hyperfine secures FDA approval for Optive AI on Swoop® system - marketscreener.com
Hyperfine receives FDA clearance for multi-direction DWI sequence - Investing.com
Hyperfine stock rises after FDA clearance for enhanced stroke imaging tech By Investing.com - Investing.com South Africa
Hyperfine stock rises after FDA clearance for enhanced stroke imaging tech - Investing.com Australia
Certain Warrants of Hyperfine, Inc. are subject to a Lock-Up Agreement Ending on 15-DEC-2025. - marketscreener.com
Certain Options of Hyperfine, Inc. are subject to a Lock-Up Agreement Ending on 15-DEC-2025. - marketscreener.com
15,055,288 Class B Common Stock of Hyperfine, Inc. are subject to a Lock-Up Agreement Ending on 15-DEC-2025. - marketscreener.com
63,525,713 Class A Common Stock of Hyperfine, Inc. are subject to a Lock-Up Agreement Ending on 15-DEC-2025. - marketscreener.com
Risk Check: Can Hyperfine Inc stock maintain growth trajectoryTrade Signal Summary & Comprehensive Market Scan Insights - moha.gov.vn
Hyperfine (HYPR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Hyperfine Inc. stock a buy in volatile markets2025 Retail Activity & Low Risk High Win Rate Stock Picks - moha.gov.vn
Hyperfine receives $3.7M Gates Foundation grant - MSN
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - BioSpace
Is Hyperfine Inc. stock gaining market shareAnalyst Downgrade & Community Consensus Stock Picks - newser.com
Why Hyperfine Inc. stock could benefit from AI revolutionQuarterly Investment Review & Weekly Breakout Stock Alerts - newser.com
Hyperfine Inc (HYPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.82%
자본화:
|
볼륨(24시간):